ReviewCancer cell international2025
Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment.
Review in Cancer cell international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exosomes and lung cancer: Biogenesis, pathogenic mechanisms, biomarkers, and therapeutic applications.The Journal of international medical research · 2026Review
- Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects.Clinical and experimental medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The reprogramming and polarization of cells within the tumor microenvironment (TME) are fundamental processes that critically influence the dynamics of tumor progression and response to therapy. These processes can either promote tumor evasion and metastasis or mount effective anti-tumor responses, thereby determining the overall tumor landscape. At the center of this dynamic interplay are exosomes that facilitate crucial intercellular communication by transferring bioactive molecules such as proteins, lipids, and nucleic acids. While the roles of individual TME components in cancer progression have been extensively characterized, the precise mechanisms through which the reprogramming of these elements favors tumor advancement remain inadequately elucidated. This review investigates the complex functions of exosomal signaling in the reprogramming and polarization of TME constituents, highlighting their dual capacity to orchestrate tumor-promoting and tumor-suppressing signals. This synthesis aims to elucidate how the modulation of TME cell behavior impacts cancer progression and contributes to the broader understanding of tumor biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.